Memcine Pharmaceuticals, Inc. is a vaccine platform company founded in 2010 to develop ImmunoplexTM, with broad applicability in both infectious diseases and oncology immunotherapy.  ImmunoplexTM is an immune complex vaccine platform that utilizes a universal antibody in all vaccines for both infectious diseases and oncology personalized medicine indications.  The antibody targets vaccine components for innate immune cell recognition and stimulates a robust adaptive immune response.  Importantly, the technology can be used to target a cancer patient’s own tumor, thus providing a personalized cancer vaccine for that specific patient and their tumor.

Contact Information
Tony Vandenbush
Memcine Pharmaceuticals,Inc.
2500 Crosspark Rd
Coralville, IA 52241
United States
Email Address: 
Phone Number: 
319-471-7803